144 related articles for article (PubMed ID: 35022348)
61. The apheresis content analysis in Allo-HSCT represents reliable influential factors on graft-versus-host disease and overall survival.
Rauofi A; Hajifathali A; Karami S; Tavakoli F; Roshandel E; Bonakchi H; Parkhideh S
Transfus Apher Sci; 2021 Apr; 60(2):103009. PubMed ID: 33608218
[TBL] [Abstract][Full Text] [Related]
62. Impact of antithymocyte globulin doses in reduced intensity conditioning before allogeneic transplantation from matched sibling donor for patients with acute myeloid leukemia: a report from the acute leukemia working party of European group of Bone Marrow Transplantation.
Devillier R; Labopin M; Chevallier P; Ledoux MP; Socié G; Huynh A; Bourhis JH; Cahn JY; Roth-Guepin G; Mufti G; Desmier D; Michallet M; Fegueux N; Ciceri F; Baron F; Blaise D; Nagler A; Mohty M
Bone Marrow Transplant; 2018 Apr; 53(4):431-437. PubMed ID: 29330391
[TBL] [Abstract][Full Text] [Related]
63. Concurrent Hepatic Tuberculosis and Hepatic Graft-versus-host Disease in an Allogeneic Hematopoietic Stem Cell Transplant Recipient: A Case Report.
Zhao Z; Leow WQ
Transplant Proc; 2017 Sep; 49(7):1659-1662. PubMed ID: 28774674
[TBL] [Abstract][Full Text] [Related]
64. Allogeneic Hematopoietic Stem Cell Transplantation in Extranodal Natural Killer/T-cell Lymphoma.
Peng YY; Xiong YY; Zhang LX; Wang J; Zhang HB; Xiao Q; Guo SL
Turk J Haematol; 2021 Jun; 38(2):126-137. PubMed ID: 33535731
[TBL] [Abstract][Full Text] [Related]
65. Alloimmune Myositis as Paraneoplastic Complication of an Oral Squamous Cell Carcinoma After Severe Chronic Graft vs Host Disease or a Manifestation of Chronic Graft vs Host Disease? A Case Report and Literature Discussion.
Woelfinger P; Hauptrock B; Kriege O; Wagner W; Heider J; Schwarting A; Birklein F; Theobald M; Wagner-Drouet EM
Transplant Proc; 2021 May; 53(4):1365-1368. PubMed ID: 33478746
[TBL] [Abstract][Full Text] [Related]
66. The impact of anti-thymocyte globulin on the outcomes of Patients with AML with or without measurable residual disease at the time of allogeneic hematopoietic cell transplantation.
Nagler A; Dholaria B; Labopin M; Socie G; Huynh A; Itälä-Remes M; Deconinck E; Yakoub-Agha I; Cahn JY; Bourhis JH; Labussière-Wallet H; Chantepie S; Esteve J; Savani B; Mohty M
Leukemia; 2020 Apr; 34(4):1144-1153. PubMed ID: 31728052
[TBL] [Abstract][Full Text] [Related]
67. The quality of life following allogeneic hematopoietic stem cell transplantation - a multicenter retrospective study.
Valkova V; Jircikova J; Trnkova M; Steinerova K; Keslova P; Lanska M; Koristek Z; Raida L; Krejci M; Kruntoradova K; Dolezal T; Benesova K; Cetkovsky P; Trneny M
Neoplasma; 2016; 63(5):743-51. PubMed ID: 27468878
[TBL] [Abstract][Full Text] [Related]
68. P16-positive secondary tongue squamous cell carcinoma following allogeneic hematopoietic stem cell transplantation: A case report and literature review.
Wu T; Liu Z; Yong X; Mei G; Jiang Q; Fang M; Li P; Zhang Z; Tao R
Oral Oncol; 2021 Oct; 121():105399. PubMed ID: 34217620
[TBL] [Abstract][Full Text] [Related]
69. Severity of acute gastrointestinal graft-vs-host disease is associated with incidence of bloodstream infection after adult allogeneic hematopoietic stem cell transplantation.
Modi A; Rybicki L; Majhail NS; Mossad SB
Transpl Infect Dis; 2020 Feb; 22(1):e13217. PubMed ID: 31769584
[TBL] [Abstract][Full Text] [Related]
70. Acute graft-versus-host disease in a nonhematopoietic stem cell transplantation candidate treated with decitabine followed by granulocyte colony-stimulating factor-primed peripheral blood stem cells infusion: a special entity of the disease?
Yuan L; Sun L; Yang L; Jing Y
Transfusion; 2014 Jan; 54(1):190-3. PubMed ID: 23621702
[TBL] [Abstract][Full Text] [Related]
71. [Gut microbiota and graft-versus-host disease: broad-spectrum antibiotic use increases post-allogeneic hematopoietic stem cell transplant graft-versus-host disease-related mortality].
Shono Y
Rinsho Ketsueki; 2017; 58(7):835-842. PubMed ID: 28781282
[TBL] [Abstract][Full Text] [Related]
72. Acute GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute myeloid leukaemia in remission: final results of quality of life and long-term outcome analysis of a phase 3 randomised study.
Bonifazi F; Solano C; Wolschke C; Sessa M; Patriarca F; Zallio F; Nagler A; Selleri C; Risitano AM; Messina G; Bethge W; Herrera P; Sureda A; Carella AM; Cimminiello M; Guidi S; Finke J; Sorasio R; Ferra C; Sierra J; Russo D; Benedetti E; Milone G; Benedetti F; Heinzelmann M; Pastore D; Jurado M; Terruzzi E; Narni F; Völp A; Ayuk F; Ruutu T; Kröger N
Lancet Haematol; 2019 Feb; 6(2):e89-e99. PubMed ID: 30709437
[TBL] [Abstract][Full Text] [Related]
73. Clinical Manifestations of Pulmonary Mucormycosis in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation: A 21-Case Series Report and Literature Review.
Bao J; Liu C; Dong Y; Xu Y; Wang Z; Sun K; Xi W; Wang K; Gong P; Gao Z
Can Respir J; 2022; 2022():1237125. PubMed ID: 35692949
[TBL] [Abstract][Full Text] [Related]
74. Outcome of allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia patients with central nervous system involvement.
Aoki J; Ishiyama K; Taniguchi S; Fukuda T; Ohashi K; Ogawa H; Kanamori H; Eto T; Iwato K; Sakamaki H; Morishima Y; Nagamura T; Atsuta Y; Takami A
Biol Blood Marrow Transplant; 2014 Dec; 20(12):2029-33. PubMed ID: 25196856
[TBL] [Abstract][Full Text] [Related]
75. Allogeneic hematopoietic stem cell transplantation can improve the prognosis of high-risk pediatric t(8;21) acute myeloid leukemia in first remission based on MRD-guided treatment.
Hu GH; Cheng YF; Lu AD; Wang Y; Zuo YX; Yan CH; Wu J; Sun YQ; Suo P; Chen YH; Chen H; Jia YP; Liu KY; Han W; Xu LP; Zhang LP; Huang XJ
BMC Cancer; 2020 Jun; 20(1):553. PubMed ID: 32539815
[TBL] [Abstract][Full Text] [Related]
76. The Superiority of Allogeneic Hematopoietic Stem Cell Transplantation Over Chemotherapy Alone in the Treatment of Acute Myeloid Leukemia Patients with Mixed Lineage Leukemia (MLL) Rearrangements.
Yang H; Huang S; Zhu CY; Gao L; Zhu HY; Lv N; Jing Y; Yu L
Med Sci Monit; 2016 Jul; 22():2315-23. PubMed ID: 27373985
[TBL] [Abstract][Full Text] [Related]
77. Clinical and serological characterization of autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation.
Yang Z; Wu B; Zhou Y; Wang W; Chen S; Sun A; Wu D; Xu Y
Chin Med J (Engl); 2014; 127(7):1235-8. PubMed ID: 24709172
[TBL] [Abstract][Full Text] [Related]
78. Busulfan-containing conditioning regimens in allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia: A Taiwan observational study.
Wang YH; Tien FM; Tsai CH; Huang HH; Liu JH; Liao XW; Tang JL; Yao M; Ko BS
Cancer Rep (Hoboken); 2022 Mar; 5(3):e1488. PubMed ID: 34196132
[TBL] [Abstract][Full Text] [Related]
79. [Clinical analysis of 104 patients with hematological malignancy after allogeneic hemotopoietic stem cell transplantation].
Chen Y; Xu Y; Zhu Y; Fu G; Liu Y; Peng J; Fu B; He Q; Wu D; Li X; Zhao X; Chen F
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Sep; 36(9):859-64. PubMed ID: 21946205
[TBL] [Abstract][Full Text] [Related]
80. Invasive mold infections in acute leukemia patients undergoing allogeneic hematopoietic stem cell transplantation.
Chien SH; Liu YC; Liu CJ; Ko PS; Wang HY; Hsiao LT; Chiou TJ; Liu JH; Gau JP
J Microbiol Immunol Infect; 2019 Dec; 52(6):973-982. PubMed ID: 30322746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]